| Total Revenue | | 7 | 0 | 0 | |
| Cost of Goods Sold Incl. D&A | | 16 | 172 | 0 |
| Gross Profit | | -9 | -172 | 0 |
| Selling, General and Administrative Excl. Other | | 29 | 48 | 46 |
| Research and Development | | 64 | 172 | 163 |
| Other Operating Expense | | -14 | -182 | 0 |
| Operating Income | | -86 | -210 | -209 |
| Interest Expense | | 0 | 0 | 0 |
| Unusual Expense | | — | — | — |
| Non-Operating Income (Expense) | | 0 | 10 | -1 |
| Net Income Before Taxes | | -86 | -155 | -208 |
| Income Taxes | | 0 | 0 | 0 |
| Consolidated Net Income | | -86 | -155 | -208 |
| Net Income From Continuing Operations | | -86 | -155 | -208 |
| Net Income | | -86 | -155 | -208 |
| EPS (Recurring) | | -34.13 | -1.98 | -3.18 |
| EPS (Basic, Before Extraordinaries) | | -34.13 | -1.98 | -3.18 |
| EPS (Diluted) | | -34.13 | -1.98 | -3.18 |
| EBITDA | | -86 | -210 | -208 |
| Other After Tax Adjustments | | — | — | — |
| Stock Option Compensation Expense | | — | — | — |
| Price To Earnings Ratio | | — | — | — |
| Price To Sales Ratio | | 37.86 | — | — |
| Gross Margin | | -128.57 | — | — |
| Operating Margin | | -1,228.57 | — | — |
| Net Margin | | -1,228.57 | — | — |
| Shares Outstanding | | 3 | 346 | 47 |
| Market Capitalization | | 265 | 11,335 | — |
| Operating Lease Expense | | — | — | — |
